COMMUNIQUÉS West-GlobeNewswire

Company Announcement No. 6/2018

20/02/2018 - 12:00

http://prlibrary-eu.nasdaq.com/Resource/Download/6a9bc9ba-416d-4113-9353-50457c40d5cb

BioCryst to Announce Fourth Quarter and Full Year 2017 Financial Results on February 27

20/02/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that its fourth quarter and full year 2017 financial results will be reported on Tuesday, [...]

Comfort Recovery Now In-Network with Humana, Aetna, and Beacon Health Options

20/02/2018 - 12:00

NORTH MIAMI, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Comfort Recovery, a national provider of drug and alcohol recovery treatment in North Miami, recently contracted with Humana, Aetna, and Beacon Health Options, three [...]

Vical Initiates Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis

20/02/2018 - 12:00

SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) announced today the initiation of a Phase 2 trial of the Company’s VL-2397 novel antifungal compound. The multicenter, open label [...]

Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, M.D., to Medical Advisory Board

20/02/2018 - 11:30

LOS ANGELES, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR ) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the gut microbiome to treat [...]

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases

20/02/2018 - 11:00

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases Alliance aims to shorten the often multi-year journey that patients and families endure before being [...]

Photocure ASA: Presentation of the fourth quarter and full year 2017 results

20/02/2018 - 10:54

Photocure will present its fourth quarter and full year 2017 report on Tuesday 27 February 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be [...]

Lundbeck increases its share capital by 8,668 shares (0.0044 % of outstanding shares) as a result of exercise of employee warrants

20/02/2018 - 10:49

Valby, Denmark, 2018-02-20 10:49 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 20 February 2018 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 43,340 as a consequence of [...]

Announcement no. 3/2018 - Share Buyback Programme

20/02/2018 - 10:44

Announcement no. 03/2018 20 February 2018 Coloplast initiates DKK 1bn share buy-back Coloplast is launching a share buy-back programme of up to DKK 1bn. The first part of the programme, of DKK 500m, is expected to take [...]

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

20/02/2018 - 09:10

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce the Company and its research arm, [...]

Zealand Pharma and UniQuest collaborate to develop novel drug candidates for gastrointestinal diseases

20/02/2018 - 09:09

Company announcement - No. 04 / 2018 Zealand Pharma and UniQuest collaborate to develop novel drug candidates for gastrointestinal diseases Combining Zealand's expertise in discovery and development of peptide [...]

Changes to Biohit Oyj’s Management Team

20/02/2018 - 08:30

Biohit Oyj Company release, 20 th February, 2018 at 9.30 a.m. local time (EET) Biohit Oyj CFO Niklas Nordström is joining another company. Search for the new CFO is ongoing. For the time being, the Chief Financial [...]

DBV Technologies Reports December 31, 2017 Cash Position

20/02/2018 - 07:31

Press Release Montrouge, France, February 20, 2018 DBV Technologies Reports December 31, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and [...]

DBV Technologies publie sa position de trésorerie au 31 décembre 2017

20/02/2018 - 07:31

Communiqué de Presse Montrouge, France, le 20 février 2018 (7h30 CET) DBV Technologies publie sa position de trésorerie au 31 décembre 2017 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), [...]

CLINUVEL unveils new global positioning

20/02/2018 - 04:47

MELBOURNE, Australia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company positioning including the [...]

Adamas Announces Declaratory Judgment Action Filed by Osmotica Related to Approved OSMOLEX ER

20/02/2018 - 02:01

EMERYVILLE, Calif., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) announced today that it has learned that Osmotica Pharmaceuticals LLC and Vertical Pharmaceuticals LCC (Osmotica) filed [...]

Burcon Announces Details of Completed Rights Offering

19/02/2018 - 19:39

VANCOUVER, British Columbia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon ") is pleased to announce that, further to its press release dated February 14, 2018 [...]

FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults

19/02/2018 - 19:00

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at Two Upcoming Healthcare Investor Conferences

19/02/2018 - 19:00

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., Feb. 19, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), today announced they will be presenting at [...]